Showing posts with label Global Industry Analysis. Show all posts
Showing posts with label Global Industry Analysis. Show all posts

Thursday, 25 August 2016

Reprocessed Medical Devices Market - Worldwide Market Shares, Strategies, and Forecasts 2014 to 2020

The global market for reprocessed medical devices features a markedly high level of consolidation, with Stryker Sustainability Solutions, Inc. alone holding a share of nearly 62% of the overall market in 2013, reports TMR in a recent market research report. Well-managed supply channels and a strong distribution network have allowed the company to take a coveted spot in the global reprocessed medical devices market.
Owing to the prominence of a few vendors in the market, entry barriers for new vendors are high. Along with the dominance of a very small number of companies, factors such as the requirement of a steady supply of used medical devices, regulatory control exercised by several supervisory bodies, and the necessity of strong distribution networks are challenging new vendors in the global reprocessed medical devices market. However, developing economies, with vast growth opportunities and a highly unorganized reprocessing industry could allow easy admittance to new vendors. Some more of the market’s notable participants are Hygia Health Services, Inc., Centurion Medical Products Corporation, Medline ReNewal, SterilMed, Inc., and SureTek Medical.
The global reprocessed medical devices market is expected to exhibit an exceptional 19.3% CAGR by revenue over the period between 2014 and 2020. The market had a revenue-wise valuation of US$898.7 mn in 2015. In terms of volume, the global market is expected to rise to 56.04 mn by 2020.
Rising Pressure on Reducing Medical Waste and Demand for Reducing Medical Costs Drive Market
That using reprocessed medical devices could help healthcare facilities in saving big bucks is not a difficult guess. The Association of Medical Device Reprocessors (AMDR) states that any typical hospital could save anywhere between US$500,000 to US$2 mn a year using reprocessed medical devices. What’s more, orthopedic surgery centers could save up to US$20,000 per operating room a year by employing reprocessed medical devices. Such vast savings are the chief factor that reprocessed medical devices appeal to healthcare industries across the globe, no matter how strong or weak the economy of a country.
In developed economies, the rising demand to bring down healthcare expenses along with the several regulations requiring proper disposal or reuse of medical devices with a view of reducing the volumes of medical waste are working in favor of the medical devices reprocessing industry. In developing and under-developed economies, on the other hand, the potential of reprocessed medical devices in bridging the gap between the vast demands for healthcare facilities and their absence, especially in remote areas, could allow the global reprocessed medical devices market achieve traction.
Reluctance in Adopting Used Products in Developed Economies and Preference for In-house Reprocessing in Emerging Ones Hinder Market’s Growth
In certain developed countries such as the U.K. and France, healthcare providers and surgical centers are highly reluctant regarding the use of reprocessed medical devices. The lack of awareness and negative perception about the safety, product quality, and efficacy of reprocessed medical devices are key to the low adoption of reprocessed medical devices in such regions.
In developing countries, such as India, China, Singapore, and many other countries in the Middle East, Africa, and Asia Pacific, the large-scale adoption of professionally reprocessed medical devices is hindered due to the high preference for in-house reprocessing.
The lack of specific regulatory guidelines governing the process of medical device reprocessing has helped flourish the intake of easily and economically reprocessed medical devices recovered through in-house processing. This factor is expected to emerge as a key challenge to the overall development of the global reprocessed medical devices market in emerging economies in the next few years.
Cardiovascular Devices Take the Lead
The segment of cardiovascular devices saw the most traction, with 13.69 mn devices reprocessed and/or sold globally in 2015. In terms of revenue as well, the segment of reprocessed cardiovascular devices held the dominant position, with a valuation of US$599.3 mn in the same year. Geography-wise, North America emerged as the clear leader in the global reprocessed medical devices market as of 2015.
This review is based on a recent report published by Transparency Market Research, titled “Reprocessed Medical Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”

Thursday, 31 March 2016

Growing Trends in Reprocessed Medical Devices Market

The global reprocessed medical devices market is expected to be valued at US$2.58 bn by the end of 2020. The market was recorded at US$0.78 bn in 2013 and is shown to be progressing at a CAGR of 19.30% within a forecast period of 2014 to 2020. The statistical details are provided in a research report released by Transparency Market Research, titled “Reprocessed Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 -2020.” The report provides a clear description of this market in terms of growth prospects as well as inhibitors, along with a competitive landscape replete with the most recent data on the top players of the market.
According to the report, the primary factor driving the reprocessed medical devices market’s growth is the increasing demand for the employment of cost-saving measures in the medical devices industry. A large number of healthcare organizations are already pushing for higher levels of recycling and reprocessing medical devices in an attempt to save on medical costs and expenditures. At the same time, these bodies are also acting in response to the growing pressure exerted by governments regarding the amount of medical waste currently generated. There is a marked increase in the number of initiatives taken by government organizations in the field of waste management, and support for the global reprocessed medical devices market is one of them.
Other significant factors promoting the global reprocessed medical devices market include the advancements in technologies that allow a better quality of reprocessed devices. This driver is applicable especially to North America.
According to the Association of Medical Device Reprocessors, a standard hospital or healthcare organization in the world can manage to generate savings of at least US$500,000 and up to US$2 mn annually, with the help of reprocessed medical devices.
The report also signals users of the various restraints that might affect the market’s growth in the near future. Of these, the most prominent inhibitor is the significantly lower level of awareness of quality reprocessed medical devices. Another hindrance to the global reprocessed medical devices market is the negative perception of patients as well as medical organizations toward reprocessing.
In terms of devices, the global reprocessed medical devices market is largely propelled by the cardiovascular devices segment, which is showing the fastest growth rate among all device types, for the given forecast period. This segment owes its growth rate to a higher rate of use and the improving quality of cardiovascular reprocessed devices.
North America dominated the global reprocessed medical devices market in 2013, due to early implementation of favorable policies and government incentives. Similar features can be seen in the European reprocessed medical devices market. Both developed regions are facing major constraints due to the rapidly increasing cost of administering medical attention.
The key players in the reprocessed medical devices market are ReNu Medical, Inc., Centurion Medical Products Corp., Hygia Health Services, Inc., MidWest Reprocessing Center, SterilMed, Inc., Medline ReNewal, SureTek Medical, Stryker Sustainability, and Vanguard AG.

Wednesday, 30 March 2016

Major Trends in the Wearable Medical Devices Industry

Wearable Medical DevicesThe rising demand for remote monitoring, especially for chronically ill patients has pushed the growth of the global wearable medical devices market. Technological advancements and increasing awareness about the importance of monitoring the vital body statistics have further augmented the market’s growth. The global wearable medical devices market is estimated to expand at a CAGR of 16.4% during the period between 2013 and 2019. The overall market was worth US$2.0 bn in 2012 and is projected to reach a valuation of US$5.80 bn by 2019.
High Cost of Wearable Medical Devices to Restrain Growth of Global Wearable Medical Devices Market
The growing prevalence of diabetes has fuelled the need to monitor blood glucose level as well as other vital signs among patients. This has boosted the demand for wearable medical devices. The ease of use and interpretation of wearable medical devices, increasing per capita income, and the rise in adoption of wearable medical devices are some of the key factors propelling the growth of the global wearable medical devices market. However, the high cost of these devices will restrain the growth of the market, especially across the emerging economies. The overall market has a huge opportunity to grow with the increasing diabetic population in Asia Pacific.
Demand for Activity Monitors to Surge in Coming Years
On the basis of product type, the global wearable medical devices market has been broadly divided into wearable diagnostic medical devices and wearable therapeutic medical devices. Wearable diagnostic medical devices have been further categorized into fetal and obstetric devices, vital signs monitor, and neuromonitoring devices. The wearable therapeutic medical devices segment has been further divided into glucose/insulin monitoring, pain management, and respiratory therapy devices. In 2012, heart rate monitors dominated the overall wearable medical devices market. Heart rate monitors were the first wearable medical devices to be made available commercially. In the near future, the demand for activity monitors is expected to surge significantly.
On the basis of application, the global wearable medical devices market is segmented into remote patient monitoring, sports and fitness, and home healthcare. While the demand from the home healthcare application segment is rising due to the growing number of chronically ill patients, the overall market is expected to be propelled by the increasing usage of wearable medical devices in sports and fitness.
Growing Demand from Asia Pacific to Drive Global Wearable Medical Devices Market
The global wearable medical devices market can be segmented into four key regions: Europe, North America, Asia Pacific, and Rest of the World. In 2012, North America dominated the overall market with 44% share. The region’s dominance in the market can be attributed to the growing demand for wearable heart rate monitors, coupled with rapid technological advancements. However, in the coming years, Asia Pacific is anticipated to register the fastest growth in the market owing to the growing demand for wearable medical devices across emerging economies such as India and China. The region is projected to expand at a CAGR of over 18% during the period between 2013 and 2019. However, the market is yet to tap the full potential of research and development activities across the region.
Key Players in Global Wearable Medical Devices Market
Some of the key players in the global wearable medical devices market are Corventis Inc., Basis Science Inc., Everist Genomics Inc., Draeger, Intelesens Ltd., Fitbit Inc., Nuubo, LifeWatch AG, Philips Electronics, Omron Corporation, Sotera Wireless, Polar Electro, Zephyr Technology Corporation, and Withings.

Sunday, 3 January 2016

Global Cell Separation Technologies Market to Exhibit 9.7% CAGR to Touch US$3.3 bn by 2019

The escalating demand for cell therapy resulting from a rise in the incidence of various chronic diseases will spur growth in the global cell separation technologies market, says Transparency Market Research in a latest study. According to the report, titled, “Cell Separation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the market will exhibit at a 9.7% CAGR between 2013 and 2019 as it rises from its 2012 valuation of US$1.7 bn to US$3.3 bn by 2019.
Browse the full Cell Separation Technologies Market (Technology: Gradient Centrifugation, MACS and FACS; Application: Stem Cell Research, Immunology, Neuroscience and Cancer Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/cell-separation-technologies.html
Governments the world over have spotted the immense revenue-generation capabilities of inviting investments in the biotechnology sector, prompting the expansion of this industry. Such initiatives will also prove conducive to the growth and development of the global cell separation technologies market, predicts TMR. Rapid progress is also being observed in cell separation techniques, making the entire process faster and more efficient. This factor will play a pivotal role in the overall growth of the global cell separation technologies market, too. The growing patient pool worldwide only underscores the need for such technologies.
A key opportunity that TMR analysts identify in the market is the need for high-purity-yield solutions that shorten turnaround time and simplify the cell separation process while keeping costs in check. Companies developing products keeping this unmet demand at the centre will be able to monetize this opportunity, says a senior TMR analyst.
The report segments the global cell separation technologies market on the basis of technology, application, and geography.Based on the technology employed, the market is segmented into gradient centrifugation and surface-marker based separation. The latter is further segmented into magnetic activated cell sorting (MACS) and fluorescence activated cell sorting (FACS). MACS represented the dominant technology segment, accounting for a sizeable 42.5% of the market (by technology) in 2012. The coming years will see the market share of FACS rise substantially thanks to the technology being increasingly used for research focusing on solutions with high-purity yields.
Likewise, the market, by application, is divided into: cancer research, stem cell research, immunology, and neuroscience research. Of these, cell separation technologies in stem cell research formed the largest segment in 2012 because of the intense focus on the use of stem cells to treat a variety of conditions and diseases.
On the basis of geography, the following regional markets have been studied in the report on the cell separation technologies market: Europe, North America, Asia Pacific, and Rest of the World. The report states that in 2012, North America was the largest regional market for cell separation technologies thanks chiefly to well-developed infrastructure supporting the market here. Moreover, generous funding for R&D related to cell separation technologies and the United States being a first mover in adopting new technologies have all shaped the dominant ranking of the cell separation technologies market in North America.
The companies profiled in the report include: Life Technologies Corporation, BD Biosciences, Miltenyi Biotec GmbH, Merck Millipore, Terumo BCT, Inc., pluriSelect GmbH, and STEMCELL Technologies, Inc.
The global cell separation technologies market is segmented as follows:
Cell Separation Technologies Market, by Technology
  • Gradient centrifugation
  • Separation based on surface markers
    • Magnetic activated cell sorting (MACS)
    • Fluorescence activated cell sorting (FACS)
Cell Separation Technologies Market, by Application
  • Stem cell research
  • Immunology
  • Neuroscience research
  • Cancer research
Cell Separation Technologies Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

Tuesday, 22 September 2015

Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

According to a new market report published by Transparency Market Research “Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”, the global cell culture media, sera, and reagents market was valued at US$3.7 bn in 2014 and is estimated to reach US$7.1 bn by 2023 at a CAGR of 7.6% from 2015 to 2023. 

The cell culture market has been extensively analyzed on the basis of media, sera, and reagents. The cell culture media segment has been sub-segmented into chemically defined, classical, lysogeny broth, protein-free, serum-free, and specialty media. The cell culture sera segment has been sub-segmented into fetal bovine serum, newborn calf and adult bovine serum, and others. The cell culture reagents segment has been sub-segmented into albumin, amino acids, attachment factors, growth factors and cytokines, protease inhibitors, and others. The albumin segment has been further studied for human serum albumin, bovine serum albumin, and recombinant serum albumin. The growth factors and cytokines segment has been studied for insulin-like growth factors, interleukins and interferon, tumor necrosis factors, and other growth factors and cytokines. The other reagents segment has been sub-segmented into porcine trypsin, recombinant trypsin, thrombin, and miscellaneous reagents.
Cell culture media has been identified as the largest segment of the cell culture media, sera, and reagents market in 2014. Cell culture industry experts are of the opinion that end-users seek high quality media that provide both reproducible results as well as robust yields. The adoption of chemically defined media has been slow yet steady for both media manufacturers and bioprocessors. Demand for media has been shifting from serum-based to serum-sparing, serum-free animal derived, and chemically-defined media. Improvements in cell productivity and cell culture have led to the adoption of smaller processes that employ single use equipment. This has increased demand for ready-to-use liquid media and media powders.

Sera provides wide range of macromolecules, trace elements, carrier proteins, spreading factors, hormones, low molecular weight nutrients, and other growth factors. Serum is commonly used as a supplement in cell culture media. Serum in general is an imprecise component of cell culture media, as a number of serum-free media formulations are being developed and introduced in the market. In addition, media without serum or animal derived components are considered ideal for the study of the role and function of small molecule drug candidates.
Cell culture reagents are chemicals that are used to synthesize or detect another substance under study in the culture. Most commonly used reagents are cell dissociation reagents, extracellular attachment matrices, cell freezing media, cell washing solutions, growth factors, amino acids and other related products.
Browse the full Press Release of Cell Culture Media, Sera, and Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/pressrelease/cell-culture-media-sera-reagents-market.htm

The global cell culture media, sera, and reagents market has been segmented as given below:
Global Cell Culture Media Market Revenue, by Type
Chemically defined
Classical
Lysogeny broth (LB)
Protein-free
Serum-free
Specialty
Global Cell Culture Sera Market Revenue, by Type
Fetal Bovine
Newborn Calf and Adult Bovine Sera
Others
Global Cell Culture Reagents Market Revenue, by Type
Albumin
Human Serum Albumin (HSA)
Bovine Serum Albumin (BSA)
Recombinant Serum Albumin (RSA)
Amino Acids
Attachment Factors
Growth Factors & Cytokines
Insulin-like Growth Factors (IGF)
HumanKine Growth Factors and Cytokine
Tumor Necrosis Factor (TNF)
Others
Hormones (Insulin, Recombinant Insulin, Erythropoietin and Others)
Others
Porcine Trypsin
Recombinant Trypsin
Thrombin
Miscellaneous Reagents
Global Cell Culture Media, Sera, and Reagents Market Revenue, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
Rest of Europe
Asia Pacific
China
India
Japan
Korea
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Rest of the World (RoW)
Israel
Russia
Rest of RoW
About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.